These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7194746)

  • 1. [Focus: platinum in chemotherapy].
    Pimentel I; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1980; 117(1):41-3. PubMed ID: 7194746
    [No Abstract]   [Full Text] [Related]  

  • 2. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platinum derivatives in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1982; 28(5):38-43. PubMed ID: 7201207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coordinated platinum compounds in experimental and clinical oncology].
    Lobanova EA; Kozlova MD; Singin AS; Serebriakov NG
    Med Radiol (Mosk); 1984 Jun; 29(6):59-63. PubMed ID: 6376996
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of chemotherapy with platinum compounds.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomonitoring of cisplatin-DNA adducts in cancer patients receiving cisplatin chemotherapy.
    Reed E; Ozols RF; Fasy T; Yuspa SH; Poirier MC
    Prog Clin Biol Res; 1986; 209B():247-52. PubMed ID: 3749082
    [No Abstract]   [Full Text] [Related]  

  • 8. [Organic compounds containing platinum and antineoplastic chemotherapy].
    Israel L; Aguilera J
    Sem Hop Ther; 1977 Nov; 53(9):470-2. PubMed ID: 601566
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review).
    Boulikas T; Vougiouka M
    Oncol Rep; 2004 Mar; 11(3):559-95. PubMed ID: 14767508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
    Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL
    Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cis-platinum in cancer chemotherapy: a significant advance.
    Helmers R; Clamon G
    J Iowa Med Soc; 1982 Nov; 72(11):464-5, 468. PubMed ID: 6890970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic markers predictive of neutropenia chemically induced by cisplatin (CDDP)].
    Gory-Delabaere G; Cupissol D; Brès J; Gau F; Constans B; Nouguier-Soulé J
    J Soc Biol; 1999; 193(1):49-55. PubMed ID: 10851556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granisetron in repeated cycles of chemotherapy with platinum.
    Tzekova VI; Velikova MT; Koynov KD
    Neoplasma; 1998; 45(1):46-9. PubMed ID: 9605002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival.
    Fisch MJ; Howard KL; Einhorn LH; Sledge GW
    Clin Cancer Res; 1996 Jun; 2(6):1063-6. PubMed ID: 9816268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future role of carboplatin.
    Ruckdeschel JC
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):114-8. PubMed ID: 7992063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.
    Gadducci A; Brunetti I; Cosio S; Giannessi PG; Genazzani AR; Conte P
    Anticancer Res; 1997; 17(6D):4703-8. PubMed ID: 9494592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.
    Blommaert FA; Michael C; Terheggen PM; Muggia FM; Kortes V; Schornagel JH; Hart AA; den Engelse L
    Cancer Res; 1993 Dec; 53(23):5669-75. PubMed ID: 8242622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal excretion of magnesium and trace elements during cisplatin treatment.
    Zumkley H; Bertram HP; Preusser P; Kellinghaus H; Straub C; Vetter H
    Clin Nephrol; 1982 May; 17(5):254-7. PubMed ID: 7201366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor active trans-platinum compounds.
    Natile G; Coluccia M
    Met Ions Biol Syst; 2004; 42():209-50. PubMed ID: 15206104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.